Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1304460rdf:typepubmed:Citationlld:pubmed
pubmed-article:1304460lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:1304460lifeskim:mentionsumls-concept:C0206694lld:lifeskim
pubmed-article:1304460lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:1304460lifeskim:mentionsumls-concept:C0016072lld:lifeskim
pubmed-article:1304460lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:1304460pubmed:issue11lld:pubmed
pubmed-article:1304460pubmed:dateCreated1993-7-7lld:pubmed
pubmed-article:1304460pubmed:abstractTextPsoralen (PSO) was found cytotoxic against in vitro cultured human mucoepidermoid carcinoma cells of MEC-1 cell line. Its IC50 value was 8.6 micrograms/ml, and relative antitumor activity (RAA) 15. PSO suppressed DNA synthesis, damaged microvilli and cell membrane, and induced degeneration of mitochondria. It inhibited the growth of MEC-1 cells transplanted in nude mice by 79.1% which was as strong as pingyanmycin (PYM 81.4%). The body weight loss of PSO treated tumor-bearing mice was 5%, whereas that of PYM treated ones 13.3% (P < 0.01). PSO may be an effective agent for the treatment of human mucoepidermoid carcinoma.lld:pubmed
pubmed-article:1304460pubmed:languageenglld:pubmed
pubmed-article:1304460pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1304460pubmed:citationSubsetIMlld:pubmed
pubmed-article:1304460pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1304460pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1304460pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1304460pubmed:statusMEDLINElld:pubmed
pubmed-article:1304460pubmed:monthNovlld:pubmed
pubmed-article:1304460pubmed:issn0366-6999lld:pubmed
pubmed-article:1304460pubmed:authorpubmed-author:WantDDlld:pubmed
pubmed-article:1304460pubmed:authorpubmed-author:ChenJ YJYlld:pubmed
pubmed-article:1304460pubmed:authorpubmed-author:LinKKlld:pubmed
pubmed-article:1304460pubmed:authorpubmed-author:EneFFlld:pubmed
pubmed-article:1304460pubmed:authorpubmed-author:LéryXXlld:pubmed
pubmed-article:1304460pubmed:issnTypePrintlld:pubmed
pubmed-article:1304460pubmed:volume105lld:pubmed
pubmed-article:1304460pubmed:ownerNLMlld:pubmed
pubmed-article:1304460pubmed:authorsCompleteYlld:pubmed
pubmed-article:1304460pubmed:pagination913-7lld:pubmed
pubmed-article:1304460pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:meshHeadingpubmed-meshheading:1304460-...lld:pubmed
pubmed-article:1304460pubmed:year1992lld:pubmed
pubmed-article:1304460pubmed:articleTitleAntitumor activity of psoralen on mucoepidermoid carcinoma cell line MEC-1.lld:pubmed
pubmed-article:1304460pubmed:affiliationStomatological Hospital, Fourth Military Medical University, Xi'an.lld:pubmed
pubmed-article:1304460pubmed:publicationTypeJournal Articlelld:pubmed